We surface undervalued gems you would never find alone. Free screening tools and expert deep analysis to lock in high-growth-potential stocks. Sophisticated algorithms and human expertise uncover opportunities others miss. Apollo Hospitals Enterprise Ltd reported robust financial results for the quarter ended March 2026, with consolidated profit after tax jumping 36% year-on-year to ₹529 crore. Revenue rose 18% to ₹6,605 crore, driven by strong operational performance across hospital, pharmacy, and diagnostics segments. The board also declared a dividend of ₹10 per share.
Live News
Apollo Hospitals Q4 Results: Profit Surges 36% YoY to ₹529 Crore, Revenue Up 18%; ₹10 Dividend DeclaredMarket participants increasingly appreciate the value of structured visualization. Graphs, heatmaps, and dashboards make it easier to identify trends, correlations, and anomalies in complex datasets.- Profit growth: Consolidated PAT rose 36% YoY to ₹529 crore, indicating improved profitability despite cost inflation pressures in the healthcare sector.
- Revenue expansion: Total income increased 18% to ₹6,605 crore, supported by higher patient footfalls, better payor mix, and robust ancillary services.
- EBITDA improvement: EBITDA grew 31% to ₹1,011 crore, with margins expanding to around 15.3%, suggesting enhanced operational efficiency.
- Dividend declared: The board proposed a ₹10 per share dividend, reflecting confidence in the company’s cash flow generation and long-term outlook.
- Segment strength: The hospital division remained the primary growth driver, while the pharmacy and diagnostics businesses also recorded double-digit revenue gains.
- Sector context: India’s healthcare industry is experiencing structural tailwinds, including rising health awareness, medical tourism, and government initiatives like Ayushman Bharat. Apollo’s results align with these broader trends.
Apollo Hospitals Q4 Results: Profit Surges 36% YoY to ₹529 Crore, Revenue Up 18%; ₹10 Dividend DeclaredMany investors adopt a risk-adjusted approach to trading, weighing potential returns against the likelihood of loss. Understanding volatility, beta, and historical performance helps them optimize strategies while maintaining portfolio stability under different market conditions.Investors often experiment with different analytical methods before finding the approach that suits them best. What works for one trader may not work for another, highlighting the importance of personalization in strategy design.Apollo Hospitals Q4 Results: Profit Surges 36% YoY to ₹529 Crore, Revenue Up 18%; ₹10 Dividend DeclaredTraders frequently use data as a confirmation tool rather than a primary signal. By validating ideas with multiple sources, they reduce the risk of acting on incomplete information.
Key Highlights
Apollo Hospitals Q4 Results: Profit Surges 36% YoY to ₹529 Crore, Revenue Up 18%; ₹10 Dividend DeclaredObserving correlations between different sectors can highlight risk concentrations or opportunities. For example, financial sector performance might be tied to interest rate expectations, while tech stocks may react more to innovation cycles.Apollo Hospitals has released its financial results for the fourth quarter of fiscal year 2025-26 (Q4 FY26), showcasing solid growth across key metrics. Consolidated net profit surged 36% compared to the same period last year, reaching ₹529 crore. Revenue from operations grew 18% to ₹6,605 crore, reflecting sustained momentum in patient volumes and higher average revenue per bed.
Earnings before interest, taxes, depreciation, and amortisation (EBITDA) rose 31% year-on-year to ₹1,011 crore, with margins improving on better operating leverage and cost efficiencies. The company’s board has recommended a final dividend of ₹10 per equity share of face value ₹5 each, subject to shareholder approval.
Management attributed the performance to strong growth in the core hospital business, which benefited from increased occupancy, higher ARPOB (average revenue per occupied bed), and a favourable case mix. The Apollo pharmacy and diagnostics divisions also contributed significantly to the top line, driven by expanded reach and higher prescription volumes.
The results come at a time when India’s healthcare sector continues to see strong demand from medical tourism, rising insurance penetration, and increased spending on preventive healthcare. Apollo Hospitals, as one of the largest healthcare chains in the country, remains a key player in that trend.
Apollo Hospitals Q4 Results: Profit Surges 36% YoY to ₹529 Crore, Revenue Up 18%; ₹10 Dividend DeclaredAccess to futures, forex, and commodity data broadens perspective. Traders gain insight into potential influences on equities.Real-time tracking of futures markets often serves as an early indicator for equities. Futures prices typically adjust rapidly to news, providing traders with clues about potential moves in the underlying stocks or indices.Apollo Hospitals Q4 Results: Profit Surges 36% YoY to ₹529 Crore, Revenue Up 18%; ₹10 Dividend DeclaredExperts often combine real-time analytics with historical benchmarks. Comparing current price behavior to historical norms, adjusted for economic context, allows for a more nuanced interpretation of market conditions and enhances decision-making accuracy.
Expert Insights
Apollo Hospitals Q4 Results: Profit Surges 36% YoY to ₹529 Crore, Revenue Up 18%; ₹10 Dividend DeclaredSome investors track currency movements alongside equities. Exchange rate fluctuations can influence international investments.The strong quarterly performance from Apollo Hospitals suggests that India’s leading healthcare providers are benefiting from a post-pandemic recovery in elective procedures and international patient inflows. The 36% YoY jump in net profit, coupled with a 31% rise in EBITDA, indicates that the company is successfully navigating input cost inflation through pricing power and scale efficiencies.
The declared dividend of ₹10 per share may be seen by market participants as a signal of management’s confidence in sustaining earnings momentum. However, investors should note that past dividend declarations do not guarantee future payouts, and any forward-looking assessments must account for potential regulatory changes, competition, and macroeconomic uncertainties.
From a sector perspective, Apollo’s results could bode well for other large hospital chains, as they often serve as a bellwether for the industry. The improving margin profile may also attract attention from analysts tracking the healthcare space, although individual company valuations will depend on factors such as debt levels, expansion plans, and regulatory compliance.
Overall, the Q4 FY26 numbers reinforce Apollo Hospitals’ position as a key player in India’s formal healthcare ecosystem, but the stock’s future trajectory would likely be influenced by broader market conditions, including interest rate movements and global risk appetite. No specific price targets or buy/sell recommendations are implied by this report.
Apollo Hospitals Q4 Results: Profit Surges 36% YoY to ₹529 Crore, Revenue Up 18%; ₹10 Dividend DeclaredSome investors prioritize simplicity in their tools, focusing only on key indicators. Others prefer detailed metrics to gain a deeper understanding of market dynamics.Analytical platforms increasingly offer customization options. Investors can filter data, set alerts, and create dashboards that align with their strategy and risk appetite.Apollo Hospitals Q4 Results: Profit Surges 36% YoY to ₹529 Crore, Revenue Up 18%; ₹10 Dividend DeclaredReal-time data supports informed decision-making, but interpretation determines outcomes. Skilled investors apply judgment alongside numbers.
